Medications
Generic semaglutide in Canada
Which generic semaglutide injections Health Canada has authorized, which are on the market, their recalls in 2026 and their public prices.
Key facts
- Health Canada authorized the first generic semaglutide injection on 2026-04-28.
- Two generic semaglutide injections show the status Marketed in the Drug Product Database: one from Dr. Reddy's and one from Apotex.
- The database has no generic tirzepatide.
- Health Canada posted three recalls of generic semaglutide lots in 2026-08.
What Health Canada has authorized
Health Canada authorized the first generic semaglutide injection on 2026-04-28. It is a product of Dr. Reddy's Laboratories and a generic of Ozempic. On that date Health Canada had eight other generic semaglutide submissions in review.
Which products are on the market
The Drug Product Database shows two generic products with the status Marketed:
- Semaglutide Injection, Dr. Reddy's Laboratories: DIN 02567806 and 02567814, marketed 2026-05-06.
- Apo-Semaglutide Injection, Apotex: DIN 02568012 and 02568020, marketed 2026-05-14.
No generic tirzepatide
The Drug Product Database has no generic tirzepatide. Each tirzepatide product in it is Mounjaro or Zepbound from Eli Lilly.
Recalls in 2026
Health Canada posted these recalls of generic semaglutide lots. All three are Type II recalls. Ask your pharmacist if a recall affects your pen.
- RA-82477 (2026-08-11): one lot of Dr. Reddy's Semaglutide Injection held a 4 mg pen with a 2 mg pen label.
- RA-82536 (2026-08-27): one lot of Apo-Semaglutide can show and deliver a 2 mg dose in place of 0.25 mg or 0.5 mg.
- RA-82537 (2026-08-26): an impurity was out of specification in the affected lots of Dr. Reddy's Semaglutide Injection.
Public prices
These prices are from the provider pages on 2026-11-12. The generic semaglutide price list of this site shows each price with its source.
- Felix: $149 for 1 pen of 0.25 mg, 0.5 mg or 1 mg.
- Phoenix: from $124.99 a month.
- Jill Health and Jack Health: from $139.